<SEC-DOCUMENT>0001638833-25-000089.txt : 20250512
<SEC-HEADER>0001638833-25-000089.hdr.sgml : 20250512
<ACCEPTANCE-DATETIME>20250512073320
ACCESSION NUMBER:		0001638833-25-000089
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250512
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250512
DATE AS OF CHANGE:		20250512

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Surgery Partners, Inc.
		CENTRAL INDEX KEY:			0001638833
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				473620923
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37576
		FILM NUMBER:		25932591

	BUSINESS ADDRESS:	
		STREET 1:		310 SEVEN SPRINGS WAY
		STREET 2:		SUITE 500
		CITY:			BRENTWOOD
		STATE:			TN
		ZIP:			37027
		BUSINESS PHONE:		615-234-5900

	MAIL ADDRESS:	
		STREET 1:		310 SEVEN SPRINGS WAY
		STREET 2:		SUITE 500
		CITY:			BRENTWOOD
		STATE:			TN
		ZIP:			37027
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>sgry-20250512.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:c593ba41-dca8-451b-b895-aa6715f5bcb6,g:add95d18-2d27-4912-a568-86fa917a0be4,d:3f7b643d6c5f4dcea31c816fe9ae2a72-->
<html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>sgry-20250512</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-24">0001638833</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-25">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="sgry-20250512.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-05-12</xbrli:startDate><xbrli:endDate>2025-05-12</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i3f7b643d6c5f4dcea31c816fe9ae2a72_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Form <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.638%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Date of Report (Date of earliest event reported):   <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">May&#160;12, 2025</ix:nonNumeric></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">Surgery Partners, Inc.</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Exact Name of Registrant as Specified in Charter)</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.500%"><tr><td style="width:1.0%"/><td style="width:32.083%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-37576</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">47-3620923</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(State or Other Jurisdiction<br/>of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-8">340 Seven Springs Way, Suite&#160;600</ix:nonNumeric></ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-9"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-10">Brentwood</ix:nonNumeric></ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-11">Tennessee</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">37027</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices) (Zip Code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">615</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">234-5900</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-17">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-18">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"/><td style="width:33.164%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.811%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.811%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.167%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-19">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-20"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-21">SGRY</ix:nonNumeric></ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-22">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Emerging growth company     </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-23">&#9744;</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i3f7b643d6c5f4dcea31c816fe9ae2a72_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02 Results of Operations and Financial Condition. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;12, 2025, Surgery Partners, Inc. issued a press release announcing results for the three months ended March&#160;31, 2025. See the press release attached as Exhibit 99.1.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgery Partners makes reference to non-GAAP financial measures in the attached press release and a reconciliation of such non-GAAP financial measures to the most directly comparable GAAP financial measures is provided therein.</span></div><div id="i3f7b643d6c5f4dcea31c816fe9ae2a72_10"></div><div style="-sec-extract:summary;margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01. Financial Statements and Exhibits. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits: </span></div><div style="margin-bottom:5pt;margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:1.0%"/><td style="width:8.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:88.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit991q12025earningsre.htm">99.1</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit991q12025earningsre.htm">Press release dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit991q12025earningsre.htm">May </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit991q12025earningsre.htm">12</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit991q12025earningsre.htm">, 2025</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i3f7b643d6c5f4dcea31c816fe9ae2a72_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:8pt;margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:507.00pt"><tr><td style="width:1.0pt"/><td style="width:25.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:173.50pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:22.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:277.75pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SURGERY PARTNERS,&#160;INC.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 12, 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  David T. Doherty</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David T. Doherty</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr></table></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit991q12025earningsre.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i512a7740e94a4cb38937b25ad5fe61f2_1"></div><div style="min-height:54pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><img alt="sgrylogoa32.jpg" src="sgrylogoa32.jpg" style="height:56px;margin-bottom:5pt;vertical-align:text-bottom;width:413px"></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2025 RESULTS </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">REAFFIRMS FULL YEAR 2025 GUIDANCE</font></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><font><br></font></div><div style="margin-bottom:9pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BRENTWOOD, Tenn.,&#160;May&#160;12, 2025 (GLOBE NEWSWIRE) -&#160;Surgery Partners, Inc.&#160;(NASDAQ&#58;SGRY) (&#8220;Surgery Partners&#8221; or the &#8220;Company&#8221;), a leading short-stay surgical facility owner and operator, today announced results for the first quarter ended&#160;March&#160;31, 2025. </font></div><div style="margin-bottom:3pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">First Quarter 2025 Financial Highlights</font></div><div style="margin-bottom:6pt;margin-top:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(All comparisons are year-over-year unless otherwise noted)</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenue increased 8.2% for the first quarter</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Same-facility revenues increased 5.2% for the first quarter</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Same-facility cases increased 6.5% for the first quarter</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net loss attributable to Surgery Partners, Inc. was $37.7 million for the first quarter</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Adjusted EBITDA increased 6.6% to $103.9 million for the first quarter </font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025 Guidance</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Full year 2025 revenue and Adjusted EBITDA guidance reaffirmed to be in the range of $3.30&#160;billion to $3.45&#160;billion and $555&#160;million to $565&#160;million, respectively</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Eric Evans, Chief Executive Officer, stated, &#8220;I am pleased with our strong start to 2025, as the Company continues to deliver growth that is consistent with Surgery Partners&#8217; long-term growth algorithm. Our continued focus on maximizing portfolio performance, advancing a robust M&#38;A pipeline and driving greater operating efficiencies, combined with a bullish outlook on surgical trends and the regulatory landscape, have us positioned to continue delivering industry leading earnings growth in 2025 and beyond.&#8221;</font></div><div style="margin-bottom:12pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dave Doherty, Chief Financial Officer, commented, &#8220;The results we report today are very much aligned with our internal expectations and give us increased confidence in reaffirming our guidance for the full year. Our guidance implies continued margin expansion, reflecting our on-going operating system improvements as well as the integration benefits from recent acquisitions and contributions from de novos we expect to open this year. We also have sufficient liquidity from our cash on hand, our revolver capacity and cash generated from operations to fund future M&#38;A activity at levels that support our long-term growth objectives without having to access incremental capital from the debt or equity markets over the next five years.&#8221;</font></div><div id="i512a7740e94a4cb38937b25ad5fe61f2_4"></div><div style="margin-bottom:6pt;margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">First Quarter 2025 Results</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues for the first quarter of 2025 increased 8.2% to $776.0 million as compared to $717.4 million for the first quarter of 2024. Same-facility revenues for the first quarter of 2025 increased 5.2% as compared to the same period in prior year, with a (1.2)% decrease in revenue per case and a 6.5% increase in same-facility cases. For the first quarter of 2025, the Company&#8217;s Adjusted EBITDA was $103.9 million, compared to $97.5 million for the same period in 2024. </font></div><div id="i512a7740e94a4cb38937b25ad5fe61f2_7"></div><div style="margin-bottom:6pt;margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgery Partners had cash and cash equivalents of $229.3 million and $388.9 million of borrowing capacity under its revolving credit facility as of March&#160;31, 2025. Cash flows from operating activities was $6.0 million for the first quarter of 2025, compared to $40.7 million for the same period in 2024. The period-over-period change is due to timing of routine transactions involving working capital.</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s ratio of total net debt to EBITDA, as calculated under the Company&#8217;s credit agreement, was approximately 4.1x at the end of the first quarter of 2025. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><div id="i512a7740e94a4cb38937b25ad5fe61f2_10"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025 Outlook</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reaffirmed its outlook for 2025 revenues and Adjusted EBITDA to be in the range of $3.30&#160;billion to $3.45&#160;billion and $555&#160;million to $565&#160;million, respectively.</font></div><div id="i512a7740e94a4cb38937b25ad5fe61f2_13"></div><div style="margin-bottom:6pt;margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Conference Call Information</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Surgery Partners will hold a conference call today, May&#160;12, 2025 at 8&#58;30 a.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-451-6152, or for international callers, 1-201-389-0879. A replay will be available three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13752904. The replay will be available until May 26, 2025.</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company's website at www.surgerypartners.com. The replay will also be available on this same website for a limited time following the call.</font></div><div style="margin-bottom:9pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To learn more about Surgery Partners, please visit the Company's website at www.surgerypartners.com. Surgery Partners uses its website as a channel of distribution for material Company information. Financial and other material information regarding Surgery Partners is routinely posted on the Company's website and is readily accessible.</font></div><div id="i512a7740e94a4cb38937b25ad5fe61f2_16"></div><div style="margin-bottom:6pt;margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">About&#160;Surgery Partners</font></div><div style="margin-bottom:9pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high quality, cost effective solutions for surgical and related ancillary care in support of both patients and physicians. Founded in 2004, Surgery Partners is one of the largest and fastest growing surgical services businesses in the country, with more than 200 locations in 30 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities. For additional information, visit www.surgerypartners.com. </font></div><div id="i512a7740e94a4cb38937b25ad5fe61f2_19"></div><div style="margin-bottom:6pt;margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This press release contains forward-looking statements, including those regarding growth, our anticipated operating results for future periods and other similar statements. These statements can be identified by the use of words such as &#34;believes,&#34; &#34;anticipates,&#34; &#34;expects,&#34; &#34;intends,&#34; &#34;plans,&#34; &#34;continues,&#34; &#34;estimates,&#34; &#34;predicts,&#34; &#34;projects,&#34; &#34;forecasts,&#34; &#34;may,&#34; &#34;could,&#34; and similar expressions. All forward-looking statements are based on current expectations and beliefs as of the date of this release and are subject to risks, uncertainties and other factors that may cause actual results to differ materially from the expectations discussed in, or implied by, the forward-looking statements. Many of these factors are beyond our ability to control or predict including, without limitation, reductions in payments from government health care programs and private insurance payors, such as health maintenance organizations, preferred provider organizations, and other managed care organizations and employers&#59; our ability to contract with private insurance payors&#59; changes in our payor mix or surgical case mix&#59; failure to maintain or develop relationships with physicians on beneficial or favorable terms, or at all&#59; the impact of payor controls designed to reduce the number of surgical procedures&#59; our efforts to integrate operations of acquired or developed businesses and surgical facilities, attract new physician partners, or acquire additional surgical facilities&#59; supply chain issues, including shortages or quality control issues with surgery-related products, equipment and medical supplies&#59; competition for physicians, nurses, strategic relationships, acquisitions and managed care contracts&#59; our ability to attract and retain qualified health care professionals&#59; our ability to enforce non-compete restrictions against our physicians&#59; our ability to manage material liabilities whether known or unknown incurred as a result of acquiring or operating surgical facilities&#59; the impact of future legislation and other health care regulatory reform actions, and the effect of that legislation and other regulatory actions on our business&#59; our ability to comply with current health care laws and regulations&#59; the outcome of legal and regulatory proceedings that have been or may be brought against us&#59; the impact of cybersecurity attacks or intrusions, changes in the regulatory, economic and other conditions of the states where our surgical facilities are located&#59; our indebtedness&#59; the social and economic impact of a pandemic, epidemic or outbreak of a contagious disease on our business&#59; and the risks and uncertainties identified and discussed from time to time in the Company&#8217;s reports filed with the SEC, including in Item 1A under the heading &#34;Risk Factors&#34; in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2024 and other reports filed with the SEC. Except as required by law, the Company undertakes no obligation to revise or update publicly any forward-looking statements to reflect events or circumstances after the date of this report, or to reflect the occurrence of unanticipated events or circumstances.</font></div><div id="i512a7740e94a4cb38937b25ad5fe61f2_22"></div><div style="margin-bottom:6pt;margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Non-GAAP Financial Measures</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the results prepared in accordance with generally accepted accounting principles in&#160;the United States&#160;(&#34;GAAP&#34;) provided throughout this press release, Surgery Partners has presented the following non-GAAP financial measures&#58; Adjusted </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">net income (loss) attributable to common stockholders, Adjusted net income (loss) per share attributable to common stockholders, Adjusted EBITDA, and Adjusted EBITDA related to unconsolidated affiliates, which exclude various items detailed in the &#34;Reconciliation of Non-GAAP Financial Measures&#34; below.</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These non-GAAP financial measures are not intended to replace financial performance measures determined in accordance with GAAP. Rather, they are presented as supplemental measures of the Company's performance that management believes may enhance the evaluation of the Company's ongoing operating results. These non-GAAP financial measures are not presented in accordance with GAAP, and the Company&#8217;s computation of these non-GAAP financial measures may vary from similar measures used by other companies. These measures have limitations as an analytical tool and should not be considered in isolation or as a substitute or alternative to revenue, net income or loss, operating income or loss, cash flows from operating activities, total indebtedness or any other measures of operating performance, liquidity or indebtedness derived in accordance with GAAP.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><div id="i512a7740e94a4cb38937b25ad5fe61f2_25"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Selected Consolidated Financial Data</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">(Dollars in millions, except per share amounts, shares in thousands)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</font></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.602%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.806%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">776.0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">717.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Salaries and benefits</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238.6&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">215.2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplies</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">215.8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188.8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional and medical fees</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82.6&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease expense</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating expenses</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.6&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenues</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">614.1&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">562.1&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expenses</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration costs</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss on disposals, consolidations and deconsolidations</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity in earnings of unconsolidated affiliates</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.6)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.7)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Litigation settlement</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.8)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.0)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">714.1&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">641.4&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.9&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.0&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62.2)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47.3)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Loss) income before income taxes</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.3)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.7&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.4)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.3)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.3&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less&#58; Net income attributable to non-controlling interests</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37.4)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36.7)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss attributable to Surgery Partners, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37.7)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12.4)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share attributable to common stockholders</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.30)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.10)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.30)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.10)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic </font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126,602&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,972&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126,602&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,972&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:3.71pt">The impact of potentially dilutive securities for all periods was not considered because the effect would be anti-dilutive.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><div id="i512a7740e94a4cb38937b25ad5fe61f2_28"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Selected Financial and Operating Data</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">(Dollars in millions, except per case and per share amounts)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</font></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:73.564%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.824%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31,<br>2025</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,<br>2024</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Data (at period end)&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">269.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,074.6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,119.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,949.2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,890.0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current maturities of long-term debt</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">569.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">624.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt, less current maturities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,446.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,268.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,362.7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,254.8&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-controlling interests&#8212;redeemable</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">430.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">438.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Surgery Partners, Inc. stockholders' equity</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,740.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,789.7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-controlling interests&#8212;non-redeemable</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,415.6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,406.7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders' equity</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,156.0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,196.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.602%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.806%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flow Data&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in)&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating activities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investing activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(76.4)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(83.1)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property and equipment</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22.7)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21.0)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments for acquisitions, net of cash acquired</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44.0)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(54.6)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of equity investments</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.8)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.0)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distributions to non-controlling interest holders</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62.3)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40.5)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.602%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.806%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Data&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of surgical facilities as of the end of period</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">165&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of consolidated surgical facilities as of the end of period</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cases</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160,300&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,392&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue per case</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,841&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,677&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA margin </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.6&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted net income per share attributable to common stockholders - Basic </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.04&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted net income per share attributable to common stockholders - Diluted </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.04&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:3.71pt">A reconciliation of these non-GAAP financial measures appears below.</font></div><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:3.71pt">Defined as Adjusted EBITDA as a % of Revenues.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><div id="i512a7740e94a4cb38937b25ad5fe61f2_31"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Supplemental Information</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">(Dollars in millions, except per case amounts)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.602%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.806%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Same-facility Information </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#58;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cases</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172,375&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164,483&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Case growth</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue per case </font></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,839&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,896&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue per case growth</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.2)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of work days in the period</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Case growth (days adjusted)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue growth (days adjusted)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:3.71pt">Same-facility information includes cases and revenues from our consolidated and non-consolidated surgical facilities (excluding facilities acquired in new markets or divested during the current and prior periods).</font></div><div id="i512a7740e94a4cb38937b25ad5fe61f2_34"></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Reconciliation of Non-GAAP Financial Measures</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">(Dollars in millions, except per share amounts, shares in thousands)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table reconciles Adjusted EBITDA to (loss) income before income taxes in the reported consolidated financial information, the most directly comparable GAAP financial measure&#58;</font></div><div style="margin-bottom:12pt;margin-top:11pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.602%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.806%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Loss) income before income taxes</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.3)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37.4)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36.7)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity-based compensation expense</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration costs </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">De novo start-up costs</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss on disposals, consolidations and deconsolidations</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Litigation settlements and other litigation costs </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.2)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.9&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.5&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:5pt;padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:3.71pt">For the three months ended March 31, 2025, this amount includes due diligence, transaction and integration costs related to acquisitions (both completed and in the pipeline) and divested facilities (collectively &#8220;M&#38;A costs&#8221;) of $16.8 million and other costs, including severance, IT implementation, revenue cycle standardization of $7.9 million. For the three months ended March 31, 2024, this amount includes due diligence, transaction and integration costs related to acquisitions (both completed and in the pipeline) and divested facilities (collectively &#8220;M&#38;A costs&#8221;) of $16.1 million and other costs, including severance, IT implementation, revenue cycle standardization of $1.3 million.</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:3.71pt">This amount includes a litigation settlement loss of $2.2 million and a litigation settlement gain of $1.8 million for the three months ended March 31, 2025 and 2024, respectively.. This amount also includes other litigation costs of $0.5 million and $0.6 million for the three months ended March 31, 2025 and 2024, respectively. </font></div><div style="margin-bottom:5pt;margin-top:3pt;padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:3.71pt">We use Adjusted EBITDA as a measure of financial performance. Adjusted EBITDA is a key measure used by management to assess operating performance, make business decisions and allocate resources. Non-controlling interests represent the interests of third parties, such as physicians, and in some cases, healthcare systems that own an interest in surgical facilities that we consolidate for financial reporting purposes. We believe that it is helpful to investors to present Adjusted EBITDA as defined above because it excludes the portion of net income attributable to these third-party interests and clarifies for investors our portion of Adjusted EBITDA generated by our surgical facilities and other operations. Adjusted EBITDA is not a measurement of financial performance under GAAP and should not be considered in isolation or as a substitute for net income, operating income or any other measure calculated in accordance with GAAP. The items excluded from Adjusted EBITDA are significant components in understanding and evaluating our financial performance. We believe such adjustments are appropriate, as the magnitude and frequency of such items can vary significantly and are not related to the assessment of normal operating performance. Our calculation of Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides supplemental information for Adjusted EBITDA related to unconsolidated affiliates&#58;</font></div><div style="margin-bottom:12pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted EBITDA related to unconsolidated affiliates&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Management fee revenues </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)(2)</font></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity in earnings of unconsolidated affiliates </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.6&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Plus&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Start-up costs related to unconsolidated de novo surgical facilities </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA related to unconsolidated affiliates</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.1&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.0&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:3.71pt">Includes management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method and management of surgical facilities in which it does not own an interest. Management fee revenues are included in Revenues on the Consolidated Statements of Operations. </font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:3.71pt">Included as a component of (loss) income before income taxes in the Adjusted EBITDA reconciliation table above.</font></div><div style="margin-bottom:9pt;margin-top:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:3.71pt">Included as a component of de novo start-up costs in the Adjusted EBITDA reconciliation table above.</font></div><div style="margin-bottom:5pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From time to time, the Company incurs certain non-recurring gains or losses that are normally non-operational in nature and management does not consider relevant in assessing its ongoing operating performance. When significant, Surgery Partners&#8217; management and the Company's Board of Directors typically exclude these gains or losses when evaluating the Company&#8217;s operating performance and in certain instances when evaluating performance for incentive compensation purposes. Additionally, management believes that certain investors and equity analysts exclude the</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">se or similar items when evaluating the Company&#8217;s current or future operating performance and in making informed investment decisions regarding the Company. Accordingly, the Company provides adjus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ted net income a</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ttributable to common stockholders and adjusted net </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">income</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> per share attributable to common stockholders as supplements to the comparable GAAP financial measures. Adjusted net </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">income</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> attributable to common stockholders and adjusted net </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">income</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> per share attributable to common stockholders should not be considered measures of financial performance under GAAP, and the items excluded from such measures are significant components in understanding and assessing financial performance. These measures should not be considered in isolation or as an alternative to the comparable GAAP measures as presented in the consolidated financial statements. </font></div><div style="margin-bottom:8pt;margin-top:5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table reconciles</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> net (loss) income as r</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">eflected in the consolidated statements of operations to adjusted net </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">income</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> attributable to common stockholders used to calculate adjusted net </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">income</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> per share attributable to common stockholders&#58; </font></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.358%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.359%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Statements of Operations Data&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.3)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Plus (minus)&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37.4)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36.7)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity-based compensation expense</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.6&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration costs</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">De novo start-up costs</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss on disposals, consolidations and deconsolidations</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Litigation settlements and other litigation costs</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.2)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted net income attributable to common stockholders</font></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.1&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted net income per share attributable to common stockholders</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.04&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.04&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126,602&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,972&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127,697&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127,357&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:14pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Contact </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Surgery Partners Investor Relations </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(615) 234-8940 </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">IR&#64;surgerypartners.com </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>sgry-20250512.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:c593ba41-dca8-451b-b895-aa6715f5bcb6,g:add95d18-2d27-4912-a568-86fa917a0be4-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sgry="http://surgerypartners.com/20250512" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://surgerypartners.com/20250512">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgry-20250512_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgry-20250512_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://surgerypartners.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>sgry-20250512_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:c593ba41-dca8-451b-b895-aa6715f5bcb6,g:add95d18-2d27-4912-a568-86fa917a0be4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_98c2afe2-729e-4d2d-b3db-7071c1e9a999_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_8b38b096-3986-4f07-9de6-e96c1db2761a_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_7da47294-9acf-448a-b67a-e6e06a1a0589_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_adb57dd7-9eb3-4d7b-8147-b7d78a0226f0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_62d6a604-14ec-461e-9e42-5cded2b22eb8_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_58c89be7-050b-4e2a-b184-8b4a6bc16e22_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_f3681298-4ac6-480e-9bf9-56b4a739b532_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_f147c248-ebd4-4d36-91ec-ad22913c3881_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_9782e816-365c-4e0a-8a8d-2314ef8b8687_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_32d610c5-54a9-4259-a1d5-8f663f8ad83d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_35b51ee5-6c79-461a-b711-2d99c9543de7_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_cac1979f-fba2-4885-acce-f8dedf4f5248_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_0145647b-6d00-44ce-82c5-a94592c36024_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_e508ee4d-d941-4d32-8c43-142610ebd2d5_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_e143b97c-d546-4f6f-ae1a-21870ac107c4_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_4969ce61-3c72-49d5-b1e6-5df57643f821_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_46058227-3969-4831-8279-4246c6b0c69d_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_1ff651a2-1f1d-4036-9637-af9f5ef8bfef_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_6deb0975-668f-48dc-a1c0-8d9a4252b6e2_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_db236099-ead7-43f8-b9dc-cc3dc2d884ab_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_8357fc41-d08e-4be6-9203-aaae4d09659b_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_42a8fd68-efc4-4bed-8a12-1a776621a3df_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>sgry-20250512_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:c593ba41-dca8-451b-b895-aa6715f5bcb6,g:add95d18-2d27-4912-a568-86fa917a0be4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://surgerypartners.com/role/Cover" xlink:type="simple" xlink:href="sgry-20250512.xsd#Cover"/>
  <link:presentationLink xlink:role="http://surgerypartners.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_35795bab-b6e5-44e7-9bdb-84f958b59447" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_25b9e38e-8fcf-4c23-a9d0-9bd325866949" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35795bab-b6e5-44e7-9bdb-84f958b59447" xlink:to="loc_dei_EntityCentralIndexKey_25b9e38e-8fcf-4c23-a9d0-9bd325866949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_2b32221e-f802-45b1-be4c-d9c9329b7ac6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35795bab-b6e5-44e7-9bdb-84f958b59447" xlink:to="loc_dei_AmendmentFlag_2b32221e-f802-45b1-be4c-d9c9329b7ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_9dc4d183-f9bb-46de-a8c1-07263615567e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35795bab-b6e5-44e7-9bdb-84f958b59447" xlink:to="loc_dei_DocumentType_9dc4d183-f9bb-46de-a8c1-07263615567e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_63b15e0f-8c58-45d5-b886-77a0c69fb6a9" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35795bab-b6e5-44e7-9bdb-84f958b59447" xlink:to="loc_dei_DocumentPeriodEndDate_63b15e0f-8c58-45d5-b886-77a0c69fb6a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a7e65ecf-51e4-4e56-bd9f-bd5fa2c9ee77" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35795bab-b6e5-44e7-9bdb-84f958b59447" xlink:to="loc_dei_EntityRegistrantName_a7e65ecf-51e4-4e56-bd9f-bd5fa2c9ee77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ff332736-985a-4fe5-86ce-838e018f0988" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35795bab-b6e5-44e7-9bdb-84f958b59447" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ff332736-985a-4fe5-86ce-838e018f0988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_68c09c58-8341-4a6b-843e-6c25dc8c3bc7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35795bab-b6e5-44e7-9bdb-84f958b59447" xlink:to="loc_dei_EntityFileNumber_68c09c58-8341-4a6b-843e-6c25dc8c3bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_01cf8d92-1217-4793-a641-58de94438056" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35795bab-b6e5-44e7-9bdb-84f958b59447" xlink:to="loc_dei_EntityTaxIdentificationNumber_01cf8d92-1217-4793-a641-58de94438056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_960a9c4d-3bd5-4658-a624-92961a4826c4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35795bab-b6e5-44e7-9bdb-84f958b59447" xlink:to="loc_dei_EntityAddressAddressLine1_960a9c4d-3bd5-4658-a624-92961a4826c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c7625f90-dd19-4fd2-a9f5-0e198bdae0e2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35795bab-b6e5-44e7-9bdb-84f958b59447" xlink:to="loc_dei_EntityAddressCityOrTown_c7625f90-dd19-4fd2-a9f5-0e198bdae0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_e29e7f56-0232-4073-8cf4-b9228e5f5d2e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35795bab-b6e5-44e7-9bdb-84f958b59447" xlink:to="loc_dei_EntityAddressStateOrProvince_e29e7f56-0232-4073-8cf4-b9228e5f5d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_ab44661a-5a35-47e7-9298-3c3dca61ebf6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35795bab-b6e5-44e7-9bdb-84f958b59447" xlink:to="loc_dei_EntityAddressPostalZipCode_ab44661a-5a35-47e7-9298-3c3dca61ebf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_fac2a933-a667-4e38-b57a-a9269ace7a8e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35795bab-b6e5-44e7-9bdb-84f958b59447" xlink:to="loc_dei_CityAreaCode_fac2a933-a667-4e38-b57a-a9269ace7a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_77a55203-2c84-407d-be70-a41c9e7a9402" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35795bab-b6e5-44e7-9bdb-84f958b59447" xlink:to="loc_dei_LocalPhoneNumber_77a55203-2c84-407d-be70-a41c9e7a9402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_c98bf05b-0344-4855-afe5-36bee4195bd2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35795bab-b6e5-44e7-9bdb-84f958b59447" xlink:to="loc_dei_WrittenCommunications_c98bf05b-0344-4855-afe5-36bee4195bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_708f4680-2cec-4a59-b9d4-29fdf3846fc0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35795bab-b6e5-44e7-9bdb-84f958b59447" xlink:to="loc_dei_SolicitingMaterial_708f4680-2cec-4a59-b9d4-29fdf3846fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_4aed8d72-838f-4180-b2e7-5ae4c26a3bfb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35795bab-b6e5-44e7-9bdb-84f958b59447" xlink:to="loc_dei_PreCommencementTenderOffer_4aed8d72-838f-4180-b2e7-5ae4c26a3bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_45dcb9a0-2e43-4ac0-922e-11db220610d6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35795bab-b6e5-44e7-9bdb-84f958b59447" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_45dcb9a0-2e43-4ac0-922e-11db220610d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_8d77ffdb-caea-48c9-b324-b404cbb19c6a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35795bab-b6e5-44e7-9bdb-84f958b59447" xlink:to="loc_dei_Security12bTitle_8d77ffdb-caea-48c9-b324-b404cbb19c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_848be9e0-346a-41f9-b7e0-8e6af53621f7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35795bab-b6e5-44e7-9bdb-84f958b59447" xlink:to="loc_dei_TradingSymbol_848be9e0-346a-41f9-b7e0-8e6af53621f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_4eb67e63-15fe-4471-80fc-04ef0de11bc8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35795bab-b6e5-44e7-9bdb-84f958b59447" xlink:to="loc_dei_SecurityExchangeName_4eb67e63-15fe-4471-80fc-04ef0de11bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_06cef9ef-4435-4337-b61f-a481c98922bc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35795bab-b6e5-44e7-9bdb-84f958b59447" xlink:to="loc_dei_EntityEmergingGrowthCompany_06cef9ef-4435-4337-b61f-a481c98922bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>sgrylogoa32.jpg
<TEXT>
begin 644 sgrylogoa32.jpg
M_]C_X13F17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    @    <@$R  (    4
M    DH=I  0    !    J    -0 +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P($-3-B H36%C:6YT;W-H*0 R,#$U.C$Q.C(P(#$U.C0Q.C,W
M  .@ 0 #     0 !  "@ @ $     0  #!Z@ P $     0   :L
M!@$#  ,    !  8   $:  4    !   !(@$;  4    !   !*@$H  ,    !
M  (   (!  0    !   !,@("  0    !   3K         !(     0   $@
M   !_]C_X@Q824-#7U!23T9)3$4  0$   Q(3&EN;P(0  !M;G1R4D="(%A9
M6B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@<U)'0@
M    ]M8  0    #3+4A0("
M                         !%C<')T   !4    #-D97-C   !A    &QW
M='!T   !\    !1B:W!T   "!    !1R6%E:   "&    !1G6%E:   "+
M !1B6%E:   "0    !1D;6YD   "5    '!D;61D   "Q    (AV=65D   #
M3    (9V:65W   #U    "1L=6UI   #^    !1M96%S   $#    "1T96-H
M   $,     QR5%)#   $/   " QG5%)#   $/   " QB5%)#   $/   " QT
M97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L971T+5!A8VMA<F0@0V]M
M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV-BTR+C$
M !)S4D="($E%0S8Q.38V+3(N,0
M                                6%E:(        /-1  $    !%LQ8
M65H@                     %A96B        !OH@  ./4   .06%E:(
M     &*9  "WA0  &-I865H@        )*    ^$  "VSV1E<V,
M%DE%0R!H='1P.B\O=W=W+FEE8RYC:               %DE%0R!H='1P.B\O
M=W=W+FEE8RYC:
M              !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@
M4D="(&-O;&]U<B!S<&%C92 M('-21T(              "Y)14,@-C$Y-C8M
M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M                9&5S8P         L4F5F97)E;F-E(%9I97=I;F<@0V]N
M9&ET:6]N(&EN($E%0S8Q.38V+3(N,0              +%)E9F5R96YC92!6
M:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M                 '9I97<      !.D_@ 47RX $,\4  /MS  $$PL  UR>
M     5A96B       $P)5@!0    5Q_G;65A<P         !
M             H\    "<VEG(     !#4E0@8W5R=@        0     !0 *
M  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4 %D 7@!C &@ ;0!R '<
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M=_P'_)C]*?VZ_DO^W/]M____[0 ,061O8F5?0TT  ?_N  Y!9&]B90!D@
M  '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,
M# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.
M#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M#/_  !$( !8 H ,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
M   #  $"! 4&!P@)"@L!  $% 0$! 0$!          $  @,$!08'" D*"Q
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M @4 !5!R:6YT #A"24T$)0      $'&R'N^RK%WYEXQ?IGQ&?D$X0DE-!#H
M     1,    0     0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O
M; $     26YT965N=6T     26YT90    !#;')M    #W!R:6YT4VEX=&5E
M;D)I=&)O;VP     "W!R:6YT97).86UE5$585    !@ 2 !0 "  3 !A ',
M90!R $H 90!T "  ,0 S #( ,  @ ', 90!R &D 90!S       /<')I;G10
M<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *
M<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F
M"7!R;V]F0TU92P X0DE-!#L      BT    0     0      $G!R:6YT3W5T
M<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B;V]L      !2
M9W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O
M;       3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;
M0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O=6) ;^
M      !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M    4G-L=%5N=$8C4'AL0'+            *=F5C=&]R1&%T86)O;VP!
M %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M          !4;W @56YT1B-2;'0               !38VP@56YT1B-0<F-
M60           !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1"
M;W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC<F]P
M4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE-
M ^T      ! !+     $  0$L     0 !.$))300F       .
M #^    X0DE-! T       0    >.$))3009       $    'CA"24T#\P
M    "0           0 X0DE-)Q        H  0         !.$))30/U
M  !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    !
M %H    &       ! #4    ! "T    &       !.$))30/X      !P  #_
M____________________________ ^@     ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@  #A"24T$"       $     $   )    "0
M   X0DE-!!X       0     .$))300:      -?    !@             !
MJP  #!X    5 %, =0!R &< 90!R 'D 4 !A '( = !N &4 <@!S $P :0!N
M &4 80!R     0                         !              P>   !
MJP                     !                         !     !
M    ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !
M  !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   !
MJP    !29VAT;&]N9P  #!X    &<VQI8V5S5FQ,<P    %/8FIC     0
M    !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO
M;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'
M96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   :L     4F=H=&QO;F<
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M4T94     $E%0R!S4D="                  #VU@ !     -,M2% @(
M
M$6-P<G0   %0    ,V1E<V,   &$    ;'=T<'0   'P    %&)K<'0   ($
M    %')865H   (8    %&=865H   (L    %&)865H   )     %&1M;F0
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M
M      !865H@        \U$  0    $6S%A96B
M6%E:(        &^B   X]0   Y!865H@        8ID  +>%   8VEA96B
M       DH   #X0  +;/9&5S8P         6245#(&AT=' Z+R]W=W<N:65C
M+F-H               6245#(&AT=' Z+R]W=W<N:65C+F-H
M                                                 &1E<V,
M    +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@
M<U)'0@              +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L
M;W5R('-P86-E("T@<U)'0@                            !D97-C
M     "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M
M,BXQ               L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN
M($E%0S8Q.38V+3(N,0                                  =FEE=P
M    $Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !6%E:(       3 E6 %
M  !7'^=M96%S          $                        "CP    )S:6<@
M     $-25"!C=7)V        !      %  H #P 4 !D '@ C "@ +0 R #<
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M.RT[:SNJ.^@\)SQE/*0\XSTB/6$]H3W@/B ^8#Z@/N _(3]A/Z(_XD C0&1
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MDI^JDE\JI)*?JI)?*J22GZJ27RJDDI__V3A"24T$(0      50    $!
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M4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@<U)'0@
M         0  ]M8  0    #3+4A0("
M                                 !%C<')T   !4    #-D97-C   !
MA    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "&    !1G6%E:
M   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D   "Q    (AV
M=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M96%S   $#
M "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/   " QB5%)#   $
M/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L971T+5!A8VMA
M<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV-BTR+C$
M         !)S4D="($E%0S8Q.38V+3(N,0
M                                        6%E:(        /-1  $
M   !%LQ865H@                     %A96B        !OH@  ./4   .0
M6%E:(        &*9  "WA0  &-I865H@        )*    ^$  "VSV1E<V,
M        %DE%0R!H='1P.B\O=W=W+FEE8RYC:               %DE%0R!H
M='1P.B\O=W=W+FEE8RYC:
M                      !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E
M9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(              "Y)14,@
M-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M                        9&5S8P         L4F5F97)E;F-E(%9I97=I
M;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0              +%)E9F5R
M96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M                         '9I97<      !.D_@ 47RX $,\4  /MS  $
M$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P         !
M                     H\    "<VEG(     !#4E0@8W5R=@        0
M    !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4 %D 7@!C &@
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M)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB\&-#8Y=CZV1
M9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(:I]J]VM/:Z=K
M_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R2W*F<P%S77.X
M=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&>J5[!'MC>\)\
M(7R!?.%]07VA?@%^8G["?R-_A'_E@$> J($*@6N!S8(P@I*"](-7@[J$'82
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MJ+C(V.CX.4E9:7F)F:FYR=GI^2HZ2EIJ>HJ:JKK*VNKZ_]H # ,!  (1 Q$
M/P#[^8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%7_T/OYBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_1^_F*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]+[^8J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7_
MT_OYBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5?_4^_F*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]7[^8J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J^>/,7GK7+#4[NSM;KA#%,Z(OI1F@!V%2I.94,8(<
M*>60-)-_RL3S#_RV?\DHO^:,EX46/C2[W?\ *Q?,/_+9_P DHO\ FG'PHKXT
MN]W_ "L7S#_RV?\ )*+_ )IQ\**^-)$6WYEZ] _.69)A_*\2@?\ "!3^.)PA
M(SR>I>6/S%L]<=;*^7ZK=ML*FJ.? 'L3X'Z"<HGB,7(AF$MB]&RIN=BKL58)
MY_\ S'T3\MK#]+>99N/.HA@C'*69AU"+MT[DT4=SN,OP:>68U%Q=5K(::/%,
M^X=2^&O-?_.7'FC5)'C\JV]OI=M4\&91/-\R7^#Z.&WB<W6+LJ$?JW^P/,Y^
MW\DOH B/F?U?8P+_ *&5_,?_ *O7_3G:?]4LO_D[%W?:?UN+_+.H_G?8/U._
MZ&5_,C_J]?\ 3G:?]4L?Y.Q=WVG]:_RSJ/YWV#]3O^AE?S(_ZO7_ $YVG_5+
M'^3L7=]I_6O\LZC^=]@_4[_H97\Q_P#J]?\ 3G:?]4L?Y.Q=WVG]:_RSJ/YW
MV#]3]!OR/\RZEYP\DZ7YB\Q3_6-1N/K/JR\$3EPN)$7X4"J**H&P_'-#K<8Q
MY#&/+;[@]9V9FEFPQE+<F_O+U?,5SG8J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%7__UOOYBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKY+\V_\=J__P"8B3]>9T.0==D^HL=R3%V*'8I=BKNG3%7TA^77F=];LVL;
MUN5W;4'(]70]"?<=#]![YB98<)<W#DXA3T;*FY)_,&N6OEG3+OS!JK%;2SA>
M:0CK1!6@'<GH!W.3QP,R(CJUY<HQ1,CR&[\>_/\ YZU+\P]9G\R:VY+2&D45
M24AB!^%$'@._B:L=SG6X, PQX0^?ZK52U$S*7]@[F%9<XSL5=BKL5=BK]7?^
M<:O_ "6^B_\ 1Y_U%RYRW:/]Z?A]P>Z[&_Q>/Q^\O=,PG9NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*O_U_OYBKL5=BKL5=BKL5=BKL5=BKL5=BKL
M5=BKL5=BKL5=BKL5=BKY+\V_\=J__P"8B3]>9T.0==D^HL=R3!O%+6*'8J[%
M+/?RUNFM]=AB4T69)(V^7$L/Q497F'I;<!J3Z9S#<Y\S?\Y8ZK+IWD7ZK"2%
MOK^WMGIW4!Y?UQC-EV7&\E]P/ZOTNF[=R<.&N\@?>?T/S'SI'BW8J[%78J[%
M75Q5^KO_ #C5_P"2XT7_ *//^HN7.6[1_O3\/N#W78W^+Q^/WE[IF$[-V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]#[^8J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J^2_-O_':O_\ F(D_7F=#D'79.98[DF+L
M4.Q2[%#L59?Y#_X[UE_KM_Q!LAE^EMP_4'U/F$Y[Y1_YS"_Y0RQ_[:\/_4//
MFT[(_O#[OTAT7M!_=#^L/N+\W,Z)X]V*NQ5V*NQ5V*OU=_YQJ_\ );Z+_P!'
MG_47+G+=H_WI^'W![KL;_%X_'[R]TS"=F[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J__1^_F*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*ODOS;_QVK__ )B)/UYG0Y!U^3F6.Y)K=BK>*NQ2UBK+_(?_ !WK+_7;
M_B!R&7DV8?J#ZGS"<]\H_P#.8?\ RAEC_P!M>'_J'GS:=D_WA]WZ0Z+V@_NA
M_6'W%^;F=$\>[%78J[WQ5V*NQ5^KO_.-7_DM]%_Z//\ J+ESENT?[T_#[@]U
MV-_B\?C]Y>Z9A.S=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_]+[
M^8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J^2_-O_':O_\
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MO^DJ/^N*N_Y7O^7?_4SZ5_TE1_UQ5W_*]_R[_P"IGTK_ *2H_P"N*N_Y7O\
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MHK*PB*B2>=@B+R-!5CL*D@?/%7G_ /RO?\N_^IGTK_I*C_KBKO\ E>_Y=_\
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M++;S(LD<B$,KHPJK*1L01N",55\5=BKL5=BKL5=BKL5=BKL5=BKL5=BKR?\
MY7O^7?\ U,^E?])4?]<5=_RO?\N_^IGTK_I*C_KBK-_+7FW1O.5J^I^5+^WU
M"TCD,+2VT@D42 !BI([@,#3W&*LAQ5V*NQ5V*NQ5@&O?FKY.\K7KZ-YCURPL
MKZ,*7@GG1'4,*@D$UW!J,52;_E>_Y=_]3/I7_25'_7%7?\KW_+O_ *F?2O\
MI*C_ *XJ[_E>_P"7?_4SZ5_TE1_UQ5W_ "O?\N_^IGTK_I*C_KBKO^5[_EW_
M -3/I7_25'_7%7?\KW_+O_J9]*_Z2H_ZXJ[_ )7O^7?_ %,^E?\ 25'_ %Q5
MW_*]_P N_P#J9]*_Z2H_ZXJ[_E>_Y=_]3/I7_25'_7%7?\KW_+O_ *F?2O\
MI*C_ *XJ[_E>_P"7?_4SZ5_TE1_UQ5W_ "O?\N_^IGTK_I*C_KBKO^5[_EW_
M -3/I7_25'_7%7J%I=PW\$5]92++;SHLD<B&JLC"JL#W!!J,51&*NQ5V*NQ5
M+M6U:RT*SFU?69X[6RMUYRS2L%1%\6)V Q5YQ_RO?\N_^IGTK_I*C_KBKO\
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MCY$AP!XR'MBE^B>%78J[%78J[%78J[%78J[%78J[%78J^8/^<P__ "5VJ?\
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M[%78J[%78J[%78J[%78J[%6#?F/^8&E_ECH%WYP\P-2"W6D<0(#S2M]B)/\
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M .2NU/\ XSV7_40F*OQIP(=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?3WY#_\
M.2^M?E/<0Z+K#R:AY59@KVS'D]N"=W@).U.I2O!M_LL>6*7Z_P"@:_I_FG3K
M;S#H%PEUI]W&)(9D.S*?Q!!V(.X(((!&%4XQ5V*NQ5^(W_.4'_DT?,7_ !GA
M_P"H>/ AX'BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK^@#\MO\
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M+7S+_P P+?\ $EQ5^&F!#L5=BKL5=BKL5=BKL5=BKL5=BKL5=BKWC\E_S_\
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M8J[%78J[%78J[%78J[%78J\:_/;\UH?RA\J7/F,<7U.4_5K"%NCSN#0D=U0
MNWC3C4%ABK\/=4U.ZUJ\GU?59GN+VZD>::60U9W<U9B?$DX$('%7LOY/?D?Y
MA_.6^:VT%5@TV!E%U?S ^E%7?B!U=Z=%'MR*@UQ5^G_Y=?\ .*_D/R D<\UD
M-7U-:%KK4 )!R\4B_NU%>FQ8?S'"E]'11)"BQ0J$111544  [ #%5^*NQ5V*
MNQ5V*L)\T_EMY6\ZJ4\U:/97S'_=DL*F0?ZL@ <?0PQ5\G>>O^<&?+6JJ]UY
M#OKC2;G<K!.3<6Y\ "2)%K_,6?\ U<5?"GYE?D-YR_*MFF\RV#/IX-%OK4F6
MW.]!5@ 4)[!PI/88$/',5?O=^3O_ "@7E;_MAZ;_ -0L>%+T?%78J[%78J[%
M7\__ .9/_*7:_P#]M6^_Y/O@0PK%7Z-_\^__ /IK?^W7_P!C.%+]&L5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5?#7_.>/_*(Z/_VU1_R8DQ5^5^!#UC\B/_)B
M>6/^VK:_\G!BK]W<*78J[%78J[%78J_!'\XO^4^\T_\ ;<U+_J*DP(><8J_0
M#_G!?RUI'F'_ !3_ (@T^TOO1_1OI_6H(Y>'+ZQRX\P:5H*TZT&%+] /^5;>
M4?\ JP:5_P!(,'_-&*N_Y5KY1_ZL&E?](,'_ #1BKO\ E6OE'_JP:5_T@P?\
MT8J[_E6WE'_JP:5_T@P?\T8JA[C\J_)5V MUY;T>4#<!]/MVI]Z8JE-W^1WY
M>WM1-Y7T@54K^[LHH]C_ *BKO[]<58?J?_.*_P"5VJ5,N@1Q.>C03W$5/H60
M+]X_'%7D?F+_ )P4\H7ZE_+FIZAITQZ"0QW$8_V)"-_P^*OD7\S?^<3_ #K^
M74,FKV\::QI,8+//9!B\:C]J2(CD!W)7FJC[3# A\QXJ[%65^2/.6I^0-;L_
M-OEZ4QWMG('&YXNO1HW ZJXJK#P/CBK]WO(WG"Q\_P"@6'G#1C_HM_"LH4FI
M1NCHU.Z,"I]QA2RS%78J[%78J[%78JD/F?S/IGDW3+CS)YDN$M=.M4YRRO\
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M0.Z2+53[BO(;<@,"& 8J[%7V]_SAI^<<GEG7!^6FMS?[B-6?_1.9VANST4>
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M ,X)?\H#J/\ VW+C_J%ML*7VIBKL5=BKL5=BK\:?^<P__)HZG_Q@LO\ J'3
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M2L/VI'/Q.?F=N@H-L*6:8J[%78J[%78J[%78J[%78J[%78J\&_-__G'CRO\
MF["]Q?Q"QUP+2/4;=0)*@;"4;"1?9OB ^RRXJ\J_YQ0_*7S#^4>I^;='\U04
MCE;3OJMU'O#<*GUBK(?;DO)30K7<=,5?9V*NQ5V*NQ5V*NQ5_.YK'^]]U_QG
ME_XD<"$MQ5^I_P#S@=_RB.L?]M4_\F(\4ON;"KL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5?!'_.>W_' T#_ )CIO^36*OS!P(9'Y._X[^E?\QUM_P G
M5Q5_0EA2[%78J[%78J[%78J[%78J\Y_,[\K="_-?2)/+_FB ,:$V]RH'K6\A
MZ/&W;M5?LL-F&*OQ'_,7R'J7Y:>8+SR=KP'UBU?X9%'PRQMNDB^S#?V-0=P<
M"&$8JSG\M/.,OD#S3I7G" L!8W4<DH7JT)/&5?\ 9(67Z<5?OS%*DR+-$P9'
M 96&X(.X(PI7XJ[%78J[%7Y3?\Y=_D./)FH-^9/E:'CH>H2TNXD&UM<O^T .
MD<IW'97JNP9!@5\1XH=BK]5_^<0_SW'G#3T_+3S3-77-/B_T.5SO<VR?LU/6
M2(;'NR4;<JYPI?;V*NQ5V*NQ5V*NQ5V*NQ5^:_\ SF+^?/UQY/RC\HS_ +B-
MA^EIXS]IP:BW!'93O)_E43]EP0K\\L4.Q5^FW_.'OY"?HB"/\V?-T'^FW"?[
MBH)!O%$PWG(/[3C9/!*MOS'$I??^*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*O
MYRL"'8J_6'_G!+_E =1_[;EQ_P!0MMA2^U,5=BKL5=BKL5=BKL5=BKL5?*'_
M #D-_P XT:;^:%I-YC\KQ1V?FR)2X=1Q2[H/L2]N9_9DZ]F)6G%5^0-W:S6$
M\MC>QM%<0NT<D;BC(ZFC*0=P010C A#XJ^I/^<1?S"?R5Y\MM(G<C3M=I83+
MV]4G]PU/'F> ]I&Q2_9'"KL5=BKL5=BKL5=BJA<W,5G#)>7;K'!$C22.QHJJ
MHJ23V &YQ5^#WYQ?F%+^:'F[4O.$G(6\\GIVL;?L6\?PQBG8D#DW^46.!#S+
M%7W#_P X1?EQ^GO,=U^8.H1UL]&3TK?D-FNI@14=CZ<=2>X+H<4I5_SFI^7?
M^&/-T7G.QCXV.NQ\WXB@6YA 60;?S+Q>O=BWABKXSQ0])_*+S_/^6/FS3?.$
M%3%;RA;E!^W;R?#*OSXDE?!@#VQ5^\=G>0:A;Q7]C(LMM/&LL4BFJLCBJL#X
M$&HPI1.*NQ5V*NQ5V*NQ5V*NQ5V*NQ5\P?\ .8?_ )*[5/\ C/9?]1"8J_&G
M AV*OZ /RV_Y1'0/^V58_P#)A,*6:XJ[%78J[%78J[%78J[%6.^:O*>D^=M,
MG\M^:+6.\T^X6CQR#H>S*>JL.JL*$'H<5?BQ^>_Y.7?Y,^8FT9V:?2;H&;3[
ME@*O'6A5J;<T)HU.OPM0!@,"O$\4(FRO9].N(M0L9#%<P2)+%(NQ5T-58>X(
MKBK]_O(/FA/.WEO2O-L0 &H6<-PRCHKNH+K_ +%JCZ,*678J[%78J[%78J[%
M78J[%78J\G_/?_R7?F?_ +95U_R;.*OPBP(=BK]N?^<7_P#R5WEW_C!-_P!1
M$F%+WS%78J[%78J[%78J[%78J[%78J[%7X]?\YH_^3*G_P"8&T_XB<"'R?BK
MZ+_YQO\ RTT_\V]5UOR7JW[N1]'EN;2Y JT$\<\*JU.ZGF0P[KX&A"EXSYP\
MI:GY%UB[\J>9(3#J%G(4D7L1U5U/=6%&4]P1BAC6*LS\@>>]5_+?7+7S=Y:E
M].[MFW5MTEC/VXW'=6&Q[CJ"& (5?M_^5_YE:5^:V@6_FOR^U%?X)X&(YP3
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M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]7[^8J[%78J[%78J[%7R_\
MF)_RD-Y_SR_Y-)F9B^EP,WU,)RQJ=BEO%#6*NQ5V*NQ5V*78H;Q5KY8I=BAW
MSQ5V*NQ5V*NVQ5V*68>006U^R"[_ !.?N1LAE^ELP_4'U-F$Y[Y1_P"<PO\
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MJKKXJRD,I\#@0QC%5RL4(="0P-01L01BK[)_*?\ YS)\Q^2XX]&\[1MKNEH
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M "KKS#_RQ_\ )6+_ )KQ\6*^#+N=_P JZ\P_\L?_ "5B_P":L?%BO@R[G?\
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M$7^N*7?]#H_F5_RT6/\ TB+_ %Q0[_H='\RO]_V/_2(O]<5=_P!#H_F5_O\
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MI?(?K:_Z'#\F?\L.K_\ (FW_ .J^/\DY.\?;^I?]$&+NE\A^MO\ Z'#\F?\
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M[%78J_G*P(=BK+-"\^^9O*UNVG^6-:U+3K5W,K16=Y- A<@ L5C8 L0 *]:
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MBL-3R(\7+#N%4X4OKD"FPZ8JWBKL5=BKL5=BKL5=BKL5=BKL5=BKR?\ /?\
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M3_SF'_Y-'5/^,%E_U#I@0^8,59CY'\@Z]^8^HGR]Y,M/KNH+$TYB]6*+]VA
M)Y2LB[%AM6N*O7/^A2OS7_ZE_P#Z?K'_ *KXJ[_H4K\U_P#J7_\ I^L?^J^*
MM_\ 0I7YK_\ 4O\ _3]8_P#5?%6O^A2OS7_ZE_\ Z?K'_JOBKO\ H4K\U_\
MJ7_^GZR_ZKXJ[_H4K\U_^I?_ .GZR_ZKXJ[_ *%*_-?_ *E__I^LO^J^*N_Z
M%*_-?_J7_P#I^L?^J^*7?]"E?FO_ -2__P!/UE_U7Q0[_H4K\U_^I?\ ^GZQ
M_P"J^*7W=_SB-^6'F;\L-(U>P\\V/U&>ZNXI(5]:&7DJQT)K$[@;^-,*OKK%
M78J[%78J[%7BO_.1G_DM?,O_ # M_P 27%7X:8$.Q5V*NQ5V*NQ5V*NQ5V*N
MQ5L DT&Y.*O:/(__ #CUY]_, I)HVCS0VC_\?5X/J\-/$%Z%Q_J!L5?>?Y6?
M\X6>7O*S1:O^8,PUO4$HPM@I6S0^ZGXI:?Y7%3T*'"E]IV]O%:Q);6J+'#&H
M5$0!551L  -@!X8JK8J[%78J[%78J[%78J[%78J[%7EGGC\E/)7YB\I/-6CV
M\UTW_'S&##/7Q,D95C3P8D>V*OE/S;_S@;I-SRG\DZW<6C=1#?1K.OR#IP*C
MYJYQ5\S>:O\ G$/\R?+/*2VL(M5@6O[S3Y@Y_P"1;\)#]"G A\\:QH.I^7IS
M8:_97-C<CK%=0O$__ N <52G%78J[%78JJ12O ZSP,R2(0RLI(((Z$$=\5?5
M/Y9?\Y>>=/(SQV7F&7]/:2M T=VQ^L*O?A/NQ/\ QDYCL*8J_2[\K/SK\K_F
M[:FX\KW/&]C4-/8ST2XBWI4K4AEK^TI9=P"0=L*7K6*NQ5V*NQ5V*NQ5V*NQ
M5__3^_F*NQ5V*NQ5V*NQ5(_,.NP>7;)]1N=R/A1.[.>@_K[9*$>(TPG/A%OE
MS6=<O->N#>:C(7;]E1]E1X*.W^=<S8Q$>3@RD9<THPL'8JWBEK%#>*M8J[%7
M8JWBKL5:Q2[%6\4-8I=BKL599Y7\VW?EJ8&)C):,?WD).Q]QX'W^_(3@),\>
M0P?3FFZC!JMM'J%DW*&5>2GO[@^X.QS#(K9SXFQ81V!+L5?#W_.0G_.0ESIU
MS/Y#\ASF&:$F.^OHS\2MT,41[$=&8;@_"M""<W6@T (XY_ ?I+S7:W:QB?#Q
M_$_H#X2=VD8R2$L[&I)-22>I)S=O+G=9A5V*NQ5V*NKBKL5=BKL5=BKL5=BK
ML5=BKL5=BJI%*\#K/"S)(A#*RD@@C<$$=",!%I!KD_0S_G'+\]Y_-;#R+YSF
M]3540FSNG^U.JC='\9% J&_;4'E\0JV@[0T(Q^N'+J.YZSLCM0Y?W>3GT/?Y
M>_[WV#FI>@=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK#/-'Y=^
M6/.JE?->D65^Q%/4FA1I!_JR4YK]!&*OFGS9_P X1^1M;#R^6YKS1ISNHCD]
M>$?-):N?HD&*OEWSA_SA'YWT+E/Y9GM-:@%:*C_5YC3_ ")3P^Z0G A\L>9/
M*&N>3[CZAYJTZZT^?>BW,+1\O=2P 8>XJ,58YBKL5=BKV;\F_P [M>_)S4UO
M-)D:?2I6'US3W8^G*O<KUX2 ?9<#V/):C%7[1>1O.VE?F)HMKYM\LR^K972U
M - Z,-F1QO1E.Q'TBH(.%++<5=BKL5=BKL5?@3^:]N+3SOYEM5-1%K.H(">_
M&Y<8$, Q5^C7_/O_ /Z:W_MU_P#8SBE^C>%78J[%78J[%78J[%78J[%78J[%
M78J[%7P1_P Y[?\ ' T#_F.F_P"36*OS!P(>L?D1_P"3$\L?]M6U_P"3@Q5^
M[N%+L5=BKL5=BKL5?@C^<7_*?>:O^VYJ?_45)@0\XQ5]"?D/^0-Q^>7Z5^J:
MG'IWZ+^K5YP&7G]8]2E*,M*>G[UKBKZ%_P"A!+__ *F:#_I";_JKBKO^A!+_
M /ZF:#_I";_JKBEW_0@FH?\ 4S0?](3?]5<5=_T()?\ _4S0?](3?]5<4*]O
M_P X!7+$BZ\TQHM-BFGLYK\C.N*7BOY[_P#.,&H?DUI]KYBL[XZMIDC>C<S"
M#T3!(3\%5YO\#C8-79A0_:7%7RSBA$6EU+8SQ7MJW&:%UD1J T934&AJ#OXX
MJ_;W\@?S;LOS<\L0ZG"L<&J682WO[:, +'(!LRKV1P*KX;K4E2<*7N&*NQ5V
M*NQ5V*NQ5V*K)8UF1H91R1P58'N#L1BK^=W5M/?2+ZYTJ>HDM9I(6!V/*-BI
M_5@0E^*OL#_G"37%TO\ ,-M,D:@U+3KB!1XNA68?\+&V*7ZZX5=BKL5=BKL5
M=BKL5=BKS?\ .'2;S7?)'F#1M(A:XO;K3KB*&)/M.[(0%'N3BK\?/^A=/S*_
MZEJ^_P"!7^N!7?\ 0NGYE?\ 4M7W_ K_ %Q0[_H73\RO^I:OO^!7^N*N_P"A
M=/S*_P"I:OO^!7^N*N_Z%T_,K_J6K[_@5_YJQ5!:E^0OY@Z/:7&KZGY?O(;.
MUB>>>5E7BD<:EF8[]  2<4O(L4.Q5^I__.!O_*(ZQ_VU3_R8CPI?<V*NQ5V*
MNQ5V*OYV]8_WONO^,\O_ !(X$)=BK]3_ /G [_E$=8_[:I_Y,1XI?<V%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78J^"/^<]O^.!H'_,=-_R:Q5^8.!"
M8Z18'5KZUTM6X&YGCA#$5X\V"UI[5Q5]\?\ 0@E__P!3-!_TA-_U5Q5W_0@E
M_P#]3-!_TA-_U5Q5W_0@E_\ ]3-!_P!(3?\ 57%+O^A!+_\ ZF:#_I";_JKB
MKO\ H02__P"IF@_Z0F_ZJXTJ*N/^<!)8K::6V\SB:Z$3&*(V'IHTE/A#/Z[D
M*3L3QKWIVQI7Y^:KI=WH=Y/H^KPO;WMK(T,T3BC(Z&C _(XH2_%7VC_SA[^<
MUMY'UEO(OF+TX],U>11!<L ##<G959NO"39=]E?B=@6.*OUDPI=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BK1%=CTQ5^1'_.5WY$C\MM7'G#RU%Q\MZI*WP(/
MAM;@U8Q^ 1MVC\*,NP45"OD+%#L5?K=_SB?^0O\ RKS3!YW\TP4\R:C'^[C<
M?%:V[;A?:1^K]P*)M\52E]CXJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J_G*.!#L5=BKL5=BKL5=BKL5=BKL5=BKTGRI^3WG7SN4_PSH=[<
M1/2DQB,<._\ Q;)Q3_AL5?7GY?\ _."FH73)>_F5J:6L.Q-I8?O)2/!I7'!3
M_JK)\\4OOCR)^6_ES\M;+]$^3;"*SB-/4<#E+*1WDD:K,=S2IH.B@#;"K.,5
M=BKL5=BKL5=BK\CO^<S/S,_Q?YN'D[3Y VFZ &A;B=FNGH93_L*".G9E?QP*
M^.\4,Y_+7RBOGKS-IOEB>9+>UN9U^L32.J+'"OQ2-R;8'B#QKU:@[XJ_<ZP\
MQ^6-+M8-,T_4=/AM;:-(88UN8@J(@"JH^+H *#"E%_XQT#_JZV/_ $DQ?\U8
MJ[_&.@?]76Q_Z28O^:L5=_C'0/\ JZV/_23%_P U8J[_ !CH'_5UL?\ I)B_
MYJQ5W^,= _ZNMC_TDQ?\U8J[_&.@?]76Q_Z28O\ FK%6)>>W\J^??+^H^3]5
MU2Q^KW]NT1;ZS%5&ZHX^+JC ,/<8J_"K5M,FT:]N='O.)N+6:2"0HP92T;%3
MQ8;$5&Q'4;X$)?BK[8_YPH_,S_#7F:?R%J4O&PUM:P!NBW<8JOR]1*K[L$&*
M7ZNX5=BKL5=BKL5=BKL5?,'_ #F'_P"2NU3_ (SV7_40F*OQIP(=BK[P\N_\
MX.7WF'2;#7T\Q0Q+?6L-R(S9L2HE0/QKZ@K2M*XI3G_H02__ .IF@_Z0F_ZJ
MXJ[_ *$$O_\ J9H/^D)O^JN*N_Z$$O\ _J9H/^D)O^JN*N_Z$$O_ /J9H/\
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MV%+L5=BKL5=BKL5?@A^<7_*?>:O^VYJ?_45)@0\YQ5^C7_/O_P#Z:W_MU_\
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M_H1+R#_U<=<_Z2+7_LFQ5W_0B?D+_JXZY_TD6O\ V38JN7_G!3R"K!CJ&N,
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M ,YF?D=ZZ-^;_EB+]X@5-6B0=5&RW%!X;*_MQ;LQP*_-S%#8-#4;'%7["?\
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M%M^(Q5^(^HZ?<Z3=3Z7J43P7=O(T4T4@HR.AHRD=B#@0@L5?:?\ SB)^>?\
M@C51^7OF6:F@ZG*/J\CGX;:Z:@&_9).C=@W%MAS.*OUBPI=BKL5=BKL5=BKL
M5=BKL5=BKL5>3_GO_P"2[\S_ /;*NO\ DV<5?A%@0[%7[<_\XO\ _DKO+O\
MQ@F_ZB),*7OF*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*OQZ_YS1_\ )E3_ /,#:?\
M$3@5\GXH?6'_ #A=_P"3*@_Y@;O_ (B,4OV%PJ[%78J[%78J[%78J[%78J^0
M_P#G*?\ ( ?F;IO^+_*T(_Q1I\?V%&]W"NYC]W7K&>^Z=P55?D0RLA*."&!H
M0=B#@0UBKWK_ )Q\_.BY_)SS$MY.7DT&]*1:C N_P _#*H_GCJ2/Y@67O4*O
M+?/-Q;7GF36+O365[.74+N2%D^R8VE8J1[$4IBK%L5?K#_S@E_R@.H_]MRX_
MZA;;"E]J8J[%78J[%78J_&G_ )S#_P#)HZI_Q@LO^H=,"'S!BK["_P"<(?\
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MRVS,);R9?]U6Z$<V^9^ROBQ&*OW9L+"WTNUATS3XUAM;:-(88UV5$0!54>P
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MW\V+^0O(UKHMH5^M7(%6).XCC!V+$=3T4;FM5#86LU@TX[R>0=EV=V<=7+N
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M*7V5Y2_/_P#+_P ZJOZ&UVT29O\ =%T_U:6O@%EX\C_J\AA5["CK(HDC(96
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ML*7W9BKL5=BKL5?,'_.8?_DKM4_XSV7_ %$)BK\:<"'8J_H _+;_ )1'0/\
MME6/_)A,*6:XJ[%78J[%78J[%78J[%5&XMXKJ)[6Y19(9%*.C"JLK"A!!Z@C
MKBK\6?\ G)'\E9/R@\QG]'*S>7=1+S6$AJ>&_P <#$]XZBA/VD*GKRH$/G;%
M62>4/->H^1]8L_-?EZ4PW]E*)(SV/9E8=U855AW!(Q5^YWY6_F/IOYJ^7;7S
M?HIXB4<+B FK03J!SC;Y'<';DI5N^%+T/%78J[%78J[%78J[%78J[%7D_P">
MW_DN_,__ &RKK_DV<5?A%@0[%7[<_P#.+_\ Y*[R[_Q@F_ZB),*7OF*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*OQ[_ .<T?_)E7'_,#:?\1.!7R=BA]8_\X7_^3*@_
MY@;O_B(Q2_83"KL5=BKL5=BKL5=BKL5=BKL54IX([J-[:Y19(9%*.C@,K*PH
M00=B".HQ5^.W_.3?Y"2?E/JWZ=\OQLWE;4'/H$5/U:4[F%CX=XR>HJ-RI)"O
MEC%#L5=BK]8?^<$O^4!U'_MN7'_4+;84OM3%78J[%78J[%7XT_\ .8?_ )-'
M5/\ C!9_]0Z8%?,&*'TE_P XL>?M!_+CSG)YA\YW?U+3VT^> 2^E++^\=XR!
MQB5VW .]*8J_1;_H;7\J/^I@_P"G&^_ZH84N_P"AM?RH_P"I@_Z<;[_JABKO
M^AM?RH_ZF#_IQOO^J&*N_P"AM?RH_P"I@_Z<;W_JABKO^AM?RH_ZF#_IQOO^
MJ&*N_P"AM?RH_P"I@_Z<;[_JABKO^AM?RH_ZF#_IQOO^J&*N_P"AM?RH_P"I
M@_Z<;[_JABKO^AM?RH_ZF#_IQOO^J&*N_P"AM?RH_P"I@_Z<;[_JABKO^AM?
MRH_ZF#_IQO?^J&*LU\B?GCY)_,R_DT+R1JGUV^A@:Y>/ZM<14B5E0MREC1?M
M.HH#7?IUQ5ZQBKL5=BKL5>*_\Y&?^2U\R_\ ,"W_ !)<5?AI@0[%7[<_\XO_
M /DKO+O_ !@F_P"HB3"E[YBKL5=BKL5=BKL5=BKL5=BK\BO^<L_R._Y5WK/^
M,_+D/'RYJLA)5!\-M<FK-'3LK[LGA\2[!14*^/\ %"/TO5+O1+RWUC297M[V
MUE2:&5#1D=#56'R(Q5^W?Y#_ )OVOYQ>6HM:7A'J]MQ@U&W4_8EILP'7A(!R
M7Z5J2IPI>UXJ[%78J[%7\[FL?[WW7_&>7_B1P(2W%60^6?-NL^3;Q=7\JW]Q
M87:T_>6\A0D UHP&S+XJP(/<8J^R/(O_ #G-YCTD):>>]/@U:$"AN(#]7G^;
M  QM\@J?/%+ZO\J?\Y>?EOYF"QW5_+I5PU/W=_"R"O\ QD3G&!\V&%7T#HOF
M?1_,B>OY=U"TOXZ<N5K/'**>-4)Q5/,5=BKL5=BK1--STQ5Y1YN_/+R)Y'5_
MT_KMFLZ#>W@D$\U>P].+DPK[@#WQ5\,_FS_SFU?ZW%+HGY76TFFV[@JVH7'$
MW)'?TT%5C_UB6;PX' KX.GN);J5[JZ=I)I&+N[DLS,QJ22=R2=R3BA1Q5]8_
M\XH?DM)^8WF)/-.LQ$^7='E660L/AGN%HR1#L0-G?_)HI^WBE^PF%78J[%78
MJ[%78J[%7__2^_F*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*OD/S';+::K>VT6R)<2!1X#D:#Z,SH&PZZ8HE)<DP;Q2[%#1Q5V*LO\ (7_'
M>LO]=O\ B#9#+]+;A^H/J?,)SWRC_P YA_\ *&6/_;7A_P"H>?-IV3_>'W?I
M#HO:#^Z']8?<7YN9T3Q[L5=BKL5=BKL5?JE_SC%8PVGY=Z9<0*%>ZDNYI2/V
MG%P\8)_V**/HSF.TC>4^5?<]QV+$# ".M_>1^A[_ )@.U=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKSS\TORWT_\UO+UQY.UJ22&
M*8K(DT5.4<B&JM0[$5Z@]1W!W"K\>OS:_(/S3^45PS:S;FYT@M2'4;=2T+ ]
M _>-O\EN_P!DL-\"'B6*NQ5V*NQ5,],UK4-&D^L:/=SVDO\ /;RM&WWJ0<5>
MAZ?^>GYA:8 EKYFU7B-@)+J24 >'[PMBK(T_YR>_-"-0B^8[B@  K% 3MXDQ
MU/TXJMF_YR;_ #/G0Q/YCN0#_+'"I^]4!&*L;U'\\/S U0%;SS-JO%NJQW<D
M8.U*40J*>V*O.K_4[S59/K.J7$US-_/-(SM][$G%4#BKL55889+F1+>W1GED
M8(B("69B:  #<DGH,5?I1_SC5_SBG)I,L'Y@?FE;@7:<9+'3)!7TCU$DZG;F
M.JI^SU;XOA4I?H1BKL5=BKL5=BKL5=BKL5?GM_SD/_SB*VJS3^=_RHB5;ERT
MMUI8HJN>I>WZ $]3&=C^Q0T4JOS<O+.?3YY+#4(I(+F)BDD4JE'1AL0RFA!'
M<' A#8J[%78JR#1O-NN>737R]J=[8'K_ *+<20]Z_L,.^*O1;'_G(7\R-/"K
M;^9=08*:CUI/6[4W]0-7Z<53?_H:#\T?^IBG_P"1-O\ ]4\52>__ .<A/S(U
M(,MQYFU%0U:^C+Z/44V],+3Z,5>;ZQYFUCS"?4U_4+N^:M:W,\DIKX_&3BJ1
MXJ[%78JSW\OORS\Q?F?J*Z)Y/LWN)*CU9C\,,*G]J23HH]OM'HH)VQ5^NOY&
M_P#./6B?DU:_6E*WWF*=*7%^Z <0>L<(-2B>._)^K;452E]!XJ[%78J[%78J
M[%78J[%7X(_G%_RGOFK_ +;FI?\ 45)@0\XQ5^C?_/O_ /Z:W_MU_P#8SBE^
MC6%78J[%78J[%78J[%78J[%78J_(C_G++\CC^76M?XQ\NP\?+FK2$E4'PVUR
M:LT?@%?=H_\ 9+0!14*^0<4(_2]3N]%O(-7TJ9[>]M9$FAE0T9'0U5@?$$8J
M_;G\AOS@M?SB\M1ZQ\,>KVO&'48%_8EILZCKPDH67PW6I*DX4O;<5=BKL5=B
MKL5=BJ6ZQHUCY@LYM&URWBN[&X4I+#,H9&4]B#_F.N*OS=_.7_G"R\TYIO,'
MY2L;JTJ7;3)6_?1CK2%SLX'96(>G=S@5\%7^GW6DW$FG:I#);W<+%)(I4*.C
M#LRL 0?GBA!XJ[%78JOBD>%A+"Q1UW#*:$?(C%6>Z9^;'G71@$TOS%JT"#]A
M+V;A_P #RI^&*LQMO^<E/S-M-HO,EV:@#]X(Y.G^NAQ5%_\ 0T'YH_\ 4Q3_
M /(FW_ZIXJE5W_SD/^9-[7UO,M^M37]W((]_;@!0>W3%6":KY]\S:ZI37-:U
M*\4[$7%Y-*#_ ,&Q\,58GBKL5=BKL59OY(_+CS)^8]W^C/)NG37L@(#NHI%'
M7O)(U$7Z3OVKBK]?/^<<?R=O?R9\N3:+K-W%=7U[<_6I1"I$<1**G!6:A?[-
M>7%>M*;5)2^@L5=BKL5=BKL5?SN:S_O?=?\ &>7_ (D<"$MQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5^L/\ S@G_ ,H%J/\ VW+C_J%ML*7VIBKL5=BKL5?!
M'_.>W_' T#_F.F_Y-8J_,' AD?D[_COZ5_S'6W_)U<5?T)84NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5\^?\ .1?Y+P_G!Y<:&Q15\PV :;3Y30<C3XH6/\L@'T,%;H#5
M5^*ES;364TEG=HT4\3M')&X*LK*:%2#N"#L1@0H8J^VO^<0?SS_P9J8_+CS/
M-QT34I?]%E<_#;W+; $GHDO0^#\3L"YQ2_5O"KL5=BKL5=BKL5=BKL5=BKL5
M?'O_ #F__P"2[B_[:MM_R;EQ5^1F!#L5?T:X4NQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_.5@0[%7ZP_\X)_\H%J/_;<N/\ J%ML*7VI
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BJ4:_KMGY8TV[\Q:Q)Z5C9027$S^"1
MJ6-!W.VP[G;%7X'^?/.%YY_\PZCYPU4GZQ?SM+QK7@G1$'LB */88%8CBA]=
M_P#.''Y9_P",_./^*M0C#:9H 6X/(5#7+U$ _P!B09*]BBUZXJ_7K"EV*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ51N+>*[BDM+I%DAE5D=&%0RL*$$=P1BK\(OS
MG_+R3\K_ #?J7E)@WU6.3U;-VWYVTGQ1FO<@?"Q_F4X$/+<5>E?E#^8$WY8^
M;=-\X0$F&"4)=(/V[>3X95IW/$DKX, >V*OWBL[R#4+>*_L9%EMIXUEBD4U5
MD<55@? @U&%*)Q5V*NQ5\P?\YA_^2NU3_C/9?]1"8J_&G AV*OZ /RU_Y1'0
M/^V58_\ )A,*6:XJ[%78J[%78J[%78J[%78J\[_-3\M]._-7RY=^4-9''U1S
MMY@*M#.H/"0?([,/VE++WQ5^&'FSRMJ/DG5[SRKYBB,.H64IBE7L>X93M56!
M#*>ZD' ACN*OHC_G'#\ZI?R@\Q Z@S-Y=U$I%?QBIX?R3*/%"=_YD+#KQHJ_
M::VN8KV&.\M'66"5%DCD0AE96%0P(V((W!PI5\5=BKL5=BKL5=BKL5=BKR?\
M]_\ R7?F?_ME77_)LXJ_"+ AV*OVY_YQ?_\ )7>7?^,$W_41)A2]\Q5V*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5^/7_ #FC_P"3*G_Y@;3_ (B<"OD_%#ZP_P"<+_\
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M78J[%78J[%78J_!'\XO^4]\U?]MS4_\ J*DP(><8J_1O_GW_ /\ 36_]NO\
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M!+_E/=1_[8=Q_P!15MBK]8<*78J[%78J\5_YR,_\EKYE_P"8%O\ B2XJ_#3
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MBT86<')+13_E,:/)_P (O9E884ON*SL[?3X(['3XHX+:)0D<42A$11L JB@
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MMY1_ZL&E?](,'_-&*N_Y5KY1_P"K!I7_ $@P?\T8J[_E6OE'_JP:5_T@P?\
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MEK-NVGZQ;0W=JY!:*>-9$)!J*JP(-#N,58S_ ,JV\H_]6#2O^D&#_FC%7?\
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M>UFX;4-8TFPN[IP TL]K%(Y %!5F4DT&PQ5 ?\JV\H_]6#2O^D&#_FC%7?\
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M/FT[)_O#[OTAT7M!_=#^L/N+\W,Z)X]V*NQ5V*MXJUBK]7?^<:O_ "6^B_\
M1Y_U%RYRW:/]Z?A]P>Z[&_Q>/Q^\O=,PG9NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*O_T_OYBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKY+\V_\=J__P"8B3]>9T.0==DYECN28.Q5O%6L5=BEFGY>QF77[,#H
M#(Q^B-LKR_2V8?J#ZBS#<]\J?\Y@1-)Y+LW05":M S'P'H3"OWD9M.R3^\/N
M_2'1^T O"/ZP^XOS9SHGCG=,5=BKL5=BKL5?J[_SC5_Y+?1?^CS_ *BY<Y;M
M'^]/P^X/==C?XO'X_>7NF83LW8J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%7__4^_F*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*ODO
MS;_QVK__ )B)/UYG0Y!U^3F6.Y)K=BKL4NQ5V*'LOY3Z*S2S:],*(H,,5>Y-
M"Q^@;?2?#*,\NCE:>/5[CF,Y3S?\V_)C>?O*FH^6X #=R1^I;5V_?1'F@J>G
M(CB3X$YD:7-X4Q+YN'K]/^8Q&'7I[P_'N:&2VD>WN%*2QL4=6%"K T(([$9U
MH-OGY%;%2PH=BKL5=BKL5?J[_P XU?\ DM]%_P"CS_J+ESENT?[T_#[@]UV-
M_B\?C]Y>Z9A.S=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_5^_F*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*ODOS;_QVK__ )B)
M/UYG0Y!U^3F6.Y)@[%#L5; [8J] \L?E_?:VZW%\K6UEU+,*,P_R0?'Q.WSR
MN>41;L>$RYOHNRLX=/@CLK- D,2A54=A_GUS$)MS0*V16!+L5?(OY\?\XZ?X
MPED\X>1U2/6&JUS:DA4N#_.I.RR>-:*W4D-4MM=#VAX?IGRZ'N=!VIV1XQX\
M?/J._P#:_/S6-$U#R_=/IFN6LUI=I]J*9"C?.AZ@]CT.;Z$Q,6#;RF3%+&:D
M*/FE>38.Q5V*NQ5^KO\ SC5_Y+?1?^CS_J+ESENT?[T_#[@]UV-_B\?C]Y>Z
M9A.S=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?__6^_F*NQ5V*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*I1-H&EW#M//96SR.269H4))
M/<DC?)<18F /13_PUI'_ %;[3_D1'_3'C/>O .YW^&M(_P"K?:?\B(_Z8\9[
MUX!W._PUI'_5OM/^1$?],>,]Z\ [D3;:-I]DWJV=I!$_\T<2J?O P&1*B("9
M8&3L5=BKL5=BJ6ZGHUAK<7U76;6"[@_WW<1+(OW,",E&9CN#3">.,Q4@#[V+
M_P#*K_)G_4NZ1_T@6_\ S1EOYG)_./S+1^2Q?S(_Z4?J=_RJ[R9_U+ND?](%
MO_S1C^9R?SC\ROY+%_,C_I1^IW_*K_)G_4NZ1_T@6_\ S1C^9R?SC\ROY+%_
M,C_I1^IW_*K_ ";_ -2[I'_2!;_\T8_F<G\X_,K^2Q?S(_Z4?J99IFEV6BVR
M:9H]O#:6<5>$,$:QQKR)8T50 *DDF@ZFN52D9&SNY$(" J(H=P1V19.Q5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*O_U_OYBKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_0^_F*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5_]'[^8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%7_TOOYBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_3^_F*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]3[^8J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
$[%7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 12, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001638833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 12,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Surgery Partners, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37576<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-3620923<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">340 Seven Springs Way, Suite&#160;600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Brentwood<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">37027<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">234-5900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SGRY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( "D\K%I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( "D\K%I[Y1WG[@   "L"   1
M9&]C4')O<',O8V]R92YX;6S-DL%JPS ,AE]E^)XH3NA@)O6EHZ<.!BML[&9L
MM36+8V-K)'W[)5Z;,K8'V-'2[T^?0*T.0ON(S]$'C&0QW8VNZY/08<U.1$$
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MM5II ,,X?<D3$L/<@HL(2W@4R]9<X%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A
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MVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA])
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M-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @
M*3RL6D;'34B5    S0   !               ( !     &1O8U!R;W!S+V%P
M<"YX;6Q02P$"% ,4    "  I/*Q:>^4=Y^X    K @  $0
M@ '#    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    "  I/*Q:F5R<(Q &
M  "<)P  $P              @ '@ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+
M 0(4 Q0    ( "D\K%K.'RL(4P0  (X0   8              " @2$(  !X
M;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    "  I/*Q:GZ ;\+$"
M  #B#   #0              @ &J#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0
M   ( "D\K%J7BKL<P    !,"   +              "  88/  !?<F5L<R\N
M<F5L<U!+ 0(4 Q0    ( "D\K%JJQ"(6,P$  "("   /              "
M 6\0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  I/*Q:)!Z;HJT   #X
M 0  &@              @ '/$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E
M;'-02P$"% ,4    "  I/*Q:99!YDAD!  #/ P  $P              @ &T
L$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #^$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="sgry-20250512.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surgerypartners.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="sgry-20250512.htm">sgry-20250512.htm</File>
    <File>sgry-20250512.xsd</File>
    <File>sgry-20250512_lab.xml</File>
    <File>sgry-20250512_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "sgry-20250512.htm": {
   "nsprefix": "sgry",
   "nsuri": "http://surgerypartners.com/20250512",
   "dts": {
    "inline": {
     "local": [
      "sgry-20250512.htm"
     ]
    },
    "schema": {
     "local": [
      "sgry-20250512.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "sgry-20250512_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sgry-20250512_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 25
   },
   "report": {
    "R1": {
     "role": "http://surgerypartners.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgry-20250512.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sgry-20250512.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001638833-25-000089-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001638833-25-000089-xbrl.zip
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MLL1#C9X)&&$\&J759Y.Y=& ]>>0Y0RLT-O4;K<VD0&@0*V/H90SZFMH9(>B
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MMD![#%;,A^Q>O=A3+WC("S"'K85:-L_JY,+'4V=RL,3AB.BJ5 9T!O9,T99
MYR/^&;MC (E@!N/VBBW%G?57CT=#Y\%R,P\G1:Y4V5J4H%+(,-5Z >A9C%-T
M^4R*T^3#V="1&-YTZG@T.'IIGP)IH :,AE(%(:S_<)CT'/]LT$\_A\/UW[I-
MH].PMO[<,,P]?VNW6GN]^=!@S8;1:^S7[($&V]FU69 )"9CFUS?-M&I>(AT
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MX<I:V;Y$H&RSV*KV"@M]"QDF"0+[V\7'[>'K6(95(!>?9L\R>UI=HUD@]E1
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MLP_IPGRZ74I3S&,MB)U+">1")9 0)J"DL8"&FH *)(*(.4ZH3\ZG$5>%!]:
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M+FAT;5!+ 0(4 Q0    ( "D\K%H@W5^>1 \   9B   1              "
M 50R  !S9W)Y+3(P,C4P-3$R+FAT;5!+ 0(4 Q0    ( "D\K%J[;7PT9P(
M  ('   1              "  <=!  !S9W)Y+3(P,C4P-3$R+GAS9%!+ 0(4
M Q0    ( "D\K%KG%CNI# H  'U4   5              "  5U$  !S9W)Y
M+3(P,C4P-3$R7VQA8BYX;6Q02P$"% ,4    "  I/*Q:AIC_!+$&  #D,
M%0              @ &<3@  <V=R>2TR,#(U,#4Q,E]P<F4N>&UL4$L%!@
0   %  4 4 $  (!5      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>sgry-20250512_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sgry-20250512.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <startDate>2025-05-12</startDate>
            <endDate>2025-05-12</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-24">0001638833</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-25">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-05-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">Surgery Partners, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-37576</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">47-3620923</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">340 Seven Springs Way, Suite&#160;600</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-8">340 Seven Springs Way, Suite&#160;600</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-9">Brentwood</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-10">Brentwood</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-11">TN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">37027</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">615</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">234-5900</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-15">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-16">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-18">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-19">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-20">SGRY</dei:TradingSymbol>
    <dei:TradingSymbol contextRef="c-1" id="f-21">SGRY</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-22">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-23">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
